Quest Diagnostics (DGX) Income from Non-Controlling Interests (2016 - 2025)
Historic Income from Non-Controlling Interests for Quest Diagnostics (DGX) over the last 17 years, with Q3 2025 value amounting to $14.0 million.
- Quest Diagnostics' Income from Non-Controlling Interests rose 2727.27% to $14.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $57.0 million, marking a year-over-year increase of 1632.65%. This contributed to the annual value of $50.0 million for FY2024, which is 740.74% down from last year.
- Quest Diagnostics' Income from Non-Controlling Interests amounted to $14.0 million in Q3 2025, which was up 2727.27% from $14.0 million recorded in Q2 2025.
- In the past 5 years, Quest Diagnostics' Income from Non-Controlling Interests ranged from a high of $23.0 million in Q4 2021 and a low of $11.0 million during Q2 2024
- In the last 5 years, Quest Diagnostics' Income from Non-Controlling Interests had a median value of $15.0 million in 2022 and averaged $15.8 million.
- As far as peak fluctuations go, Quest Diagnostics' Income from Non-Controlling Interests skyrocketed by 20000.0% in 2021, and later crashed by 4000.0% in 2023.
- Quarter analysis of 5 years shows Quest Diagnostics' Income from Non-Controlling Interests stood at $23.0 million in 2021, then crashed by 34.78% to $15.0 million in 2022, then decreased by 13.33% to $13.0 million in 2023, then grew by 7.69% to $14.0 million in 2024, then changed by 0.0% to $14.0 million in 2025.
- Its last three reported values are $14.0 million in Q3 2025, $14.0 million for Q2 2025, and $15.0 million during Q1 2025.